![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:COL4A2-NUBPL (FusionGDB2 ID:HG1284TG80224) |
Fusion Gene Summary for COL4A2-NUBPL |
![]() |
Fusion gene information | Fusion gene name: COL4A2-NUBPL | Fusion gene ID: hg1284tg80224 | Hgene | Tgene | Gene symbol | COL4A2 | NUBPL | Gene ID | 1284 | 80224 |
Gene name | collagen type IV alpha 2 chain | nucleotide binding protein like | |
Synonyms | BSVD2|ICH|POREN2 | C14orf127|IND1|MC1DN21|huInd1 | |
Cytomap | ('COL4A2')('NUBPL') 13q34 | 14q12 | |
Type of gene | protein-coding | protein-coding | |
Description | collagen alpha-2(IV) chaincanstatin | iron-sulfur protein NUBPLIND1 homologiron-sulfur protein required for NADH dehydrogenase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P08572 | . | |
Ensembl transtripts involved in fusion gene | ENST00000360467, ENST00000462309, | ||
Fusion gene scores | * DoF score | 15 X 13 X 10=1950 | 17 X 14 X 7=1666 |
# samples | 17 | 17 | |
** MAII score | log2(17/1950*10)=-3.51986747249927 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(17/1666*10)=-3.29278174922785 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: COL4A2 [Title/Abstract] AND NUBPL [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | COL4A2(110960470)-NUBPL(32068495), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | COL4A2-NUBPL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL4A2-NUBPL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | COL4A2 | GO:0016525 | negative regulation of angiogenesis | 10625665 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-FX-A48G-01A | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
Top |
Fusion Gene ORF analysis for COL4A2-NUBPL |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000360467 | ENST00000418681 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
In-frame | ENST00000360467 | ENST00000281081 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
In-frame | ENST00000360467 | ENST00000536705 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
intron-3CDS | ENST00000462309 | ENST00000281081 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
intron-3CDS | ENST00000462309 | ENST00000536705 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
intron-intron | ENST00000462309 | ENST00000418681 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000360467 | COL4A2 | chr13 | 110960470 | - | ENST00000281081 | NUBPL | chr14 | 32068495 | + | 3118 | 405 | 273 | 1073 | 266 |
ENST00000360467 | COL4A2 | chr13 | 110960470 | - | ENST00000536705 | NUBPL | chr14 | 32068495 | + | 3087 | 405 | 273 | 1073 | 266 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000360467 | ENST00000281081 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + | 0.000492937 | 0.99950707 |
ENST00000360467 | ENST00000536705 | COL4A2 | chr13 | 110960470 | - | NUBPL | chr14 | 32068495 | + | 0.000472755 | 0.9995272 |
Top |
Fusion Genomic Features for COL4A2-NUBPL |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
![]() |
![]() |
Top |
Fusion Protein Features for COL4A2-NUBPL |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:110960470/chr14:32068495) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
COL4A2 | . |
FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; FUNCTION: Canstatin, a cleavage product corresponding to the collagen alpha 2(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity. It inhibits proliferation and migration of endothelial cells, reduces mitochondrial membrane potential, and induces apoptosis. Specifically induces Fas-dependent apoptosis and activates procaspase-8 and -9 activity. Ligand for alphavbeta3 and alphavbeta5 integrins. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | COL4A2 | chr13:110960470 | chr14:32068495 | ENST00000360467 | - | 3 | 48 | 1489_1712 | 33 | 1713.0 | Domain | Collagen IV NC1 |
Hgene | COL4A2 | chr13:110960470 | chr14:32068495 | ENST00000360467 | - | 3 | 48 | 184_1484 | 33 | 1713.0 | Region | Note=Triple-helical region |
Tgene | NUBPL | chr13:110960470 | chr14:32068495 | ENST00000281081 | 2 | 11 | 75_82 | 97 | 320.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for COL4A2-NUBPL |
![]() |
>18359_18359_1_COL4A2-NUBPL_COL4A2_chr13_110960470_ENST00000360467_NUBPL_chr14_32068495_ENST00000281081_length(transcript)=3118nt_BP=405nt GGGAGCGCGCGGCCCGGGAGTGTGGCTGCAGTGCGCCGGGACACCAGGGCTCCGCGCTCCGCACTCAAGAGGCTCCCGCGTCCCAACCCC TCGCGCCCGCGCGTTCGCGGATCCAGGCCGAGGACCGAAAGGGGCCGCCCGAGCCCCCGGGGCCGGCGCCCAGAGAGCCCAGCAAGGCCG GCCGCCCTGCCGGTGTGCCGCCGGCGGGTGCTTCTGGAAGGGCCAATGCGTTCGGGCAGCAGCCCCTGAAGCCGAGCCCGAGGCTAAGTG GGACTGACCGGGGCCCAGAGTGGACGAACCGCCAGCATGGGGAGAGACCAGCGCGCGGTGGCCGGCCCTGCCCTACGGCGGTGGCTGCTG CTGGGGACAGTGACCGTGGGGTTCCTCGCCCAGAGCGTCTTGGCGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCA GTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGAGCAACCTAATGAGGCCTCTCTTGAATTATGGTATTGCTTGTATG TCTATGGGCTTTCTGGTTGAAGAAAGTGAACCAGTAGTTTGGAGAGGCCTTATGGTAATGTCGGCCATTGAGAAATTGTTGAGGCAGGTA GATTGGGGTCAACTGGACTACTTAGTTGTAGACATGCCACCAGGAACTGGAGATGTGCAGTTATCAGTCTCACAGAATATTCCTATAACA GGTGCTGTGATTGTCTCCACGCCCCAGGACATCGCATTGATGGATGCACACAAGGGTGCTGAGATGTTTCGCAGAGTCCACGTGCCCGTC CTTGGCCTTGTCCAAAACATGAGTGTTTTCCAGTGTCCAAAATGTAAACACAAAACTCATATTTTTGGTGCTGATGGTGCAAGGAAACTA GCACAGACCCTTGGTCTTGAAGTTCTAGGAGACATTCCCTTACACCTTAATATAAGGGAAGCTTCAGATACAGGCCAGCCAATTGTGTTT TCACAGCCTGAAAGTGATGAGGCCAAAGCTTACTTGAGGATTGCTGTGGAAGTGGTAAGAAGATTGCCATCACCTTCAGAATGATTCCCC AAGTGTCCTGGAAATTTGCCTGGTACTGACATTAAGAGGACCTTTGGAAATCAGCAATGTGGTGATGGAACCTACAGAAATAATAGAAAT CATAACTGTTTTATTTCTAAGGAAAGAATGTCTTCATATTTGACTTGCTAAGCTAAGGTTCACAAAACTTTGATGTATCAATGTTAACTG CTATATTTAGGAATTTTTTGAAAGCTGGTGTGTACCACCTGCAAAGAACTGCATTTTATTTTATTGAATTACCCCTTTAGAAATCACGAG TTTATGATGTTACAAGTCCATTTTGGGAGAGAACTGTACACTTTTTGCAGGACCACAGAATTAGTAATTTAAATGATATACTAAATTTGT GTATGGGCATAAGTATTACGCCTTCCCACCAGGCAATTTGGACTGTCTTTGAATCCTGTCTTTGGTACTGTCTTGGACATGTTCTTAATA TGAACCTCTGCTTCTTCATCTGGATCACACTATACCCCAGACTTAATGAATTTCAGTCTCCAGGAGTGGAGCCTGAACATATGTATTTTT AGTAAGACCATGATGATGTTGATGATGATTCTGGTAATCATGGCAGTAAGAATAATAGCTAACATTTAACAAGTTAATTATAATTGTTCT TCCATTTGTGTGAGTGGGTACTATTATCTCCATTTTACAGATAAGTAATTTGAGATATAATTTGAAGGCACTCAACCTTGAGTGTCTTGC TGAGGGTTACTGTATCTAGCAGGTGATGGAGCTTGGATTTGAACTTGAGTAATTCGATATTAGATTCATCTTTTTGTACACCAATGTGCT TTTGTTAATTAAAAAAAGTCGGTGGTGGCTAGGCGTGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGTTGAGGTGGGTGGATCAT GAGGTCAGGAGTTCAAGACCAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCTGGGTGTGGTGGCATATG CCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCATTTCAACCCGGGAGGCTGAGGTTGCAGTGAGTGGAGATTGTACCACTG CACTCCAGCCTGGTCAATGGAGTGCGACTCCATCTCAAAAAAAAAAAAAAAAAAAAAAAAAGTCGGGGGAGATGCAATATTTAGCATTTC CTCAAACTTTTTTTGGCCATGAAATCCACCACCCCCCTCCTTTTTCAGAGCATTTCATGAAGTTCACATTTCAAATAATACATTTTGAAA AACATTTATCTTGTCTAATTGAAGCTCAAAGAGATAGAGTCAATGACTTTTCAAAGTCAGGTAGCAGATAGTTTTAAAGCTGCAAGTACT GATAAGTGTGAGCCATTAGTTAATTCGCATTTATAAAGAAGTGGTCTGTCACTTTTGGCAAATGTCTTGACATCTGTTGCTCTACAGTTG TCAACTAGAAAATTAGGCATAGAGTTTCACATTATTATAAGCATGTTTTCACACAAAAACATGTACATTGATGTTTATTGCAATTTTATG TGTAATAACCAAAAACAACCCAGATTTTCTTCATTGGGTAAATGATTAAACAAACCATAGTACATTCATACCGTGAGTGCTACTCAGCAA TAAAAAAGAACAAACTATGGGTACAGGCAGCAACTTATAATTCCAGAGAATTATGCTGAATGAAAAAGGCCAATTTAAAAAGGTTTTGTA CCAAAAGATTCCATTTATATAACGTTCTTGAAGTGACATAATTATAGAAATGGAGAACAGATTAGTGGTGGCTGTGTTAAGGAGGGGGTG AGGATGGGAGAGAATTGGGCGTGGCTGTGAGAAACATGAGGGATCCTTGTGATGATGGAAATGTTCTATATCACAGCTATCGATGTCAGT ATCCCAGTTGTGATATTGTGCTATAGTTTTGCAAGATGTTACCACTGGGGGAAATTGGGTGAAGGGCACATGGAATCTCTGTATTATTTC AACTGCATGTAAATCTACAATTATCTCAAAATAAAAATAAAAGTTAAAAAAACACAAA >18359_18359_1_COL4A2-NUBPL_COL4A2_chr13_110960470_ENST00000360467_NUBPL_chr14_32068495_ENST00000281081_length(amino acids)=266AA_BP=42 MTGAQSGRTASMGRDQRAVAGPALRRWLLLGTVTVGFLAQSVLASKAIGLLDVDVYGPSVPKMMNLKGNPELSQSNLMRPLLNYGIACMS MGFLVEESEPVVWRGLMVMSAIEKLLRQVDWGQLDYLVVDMPPGTGDVQLSVSQNIPITGAVIVSTPQDIALMDAHKGAEMFRRVHVPVL GLVQNMSVFQCPKCKHKTHIFGADGARKLAQTLGLEVLGDIPLHLNIREASDTGQPIVFSQPESDEAKAYLRIAVEVVRRLPSPSE -------------------------------------------------------------- >18359_18359_2_COL4A2-NUBPL_COL4A2_chr13_110960470_ENST00000360467_NUBPL_chr14_32068495_ENST00000536705_length(transcript)=3087nt_BP=405nt GGGAGCGCGCGGCCCGGGAGTGTGGCTGCAGTGCGCCGGGACACCAGGGCTCCGCGCTCCGCACTCAAGAGGCTCCCGCGTCCCAACCCC TCGCGCCCGCGCGTTCGCGGATCCAGGCCGAGGACCGAAAGGGGCCGCCCGAGCCCCCGGGGCCGGCGCCCAGAGAGCCCAGCAAGGCCG GCCGCCCTGCCGGTGTGCCGCCGGCGGGTGCTTCTGGAAGGGCCAATGCGTTCGGGCAGCAGCCCCTGAAGCCGAGCCCGAGGCTAAGTG GGACTGACCGGGGCCCAGAGTGGACGAACCGCCAGCATGGGGAGAGACCAGCGCGCGGTGGCCGGCCCTGCCCTACGGCGGTGGCTGCTG CTGGGGACAGTGACCGTGGGGTTCCTCGCCCAGAGCGTCTTGGCGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCA GTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGAGCAACCTAATGAGGCCTCTCTTGAATTATGGTATTGCTTGTATG TCTATGGGCTTTCTGGTTGAAGAAAGTGAACCAGTAGTTTGGAGAGGCCTTATGGTAATGTCGGCCATTGAGAAATTGTTGAGGCAGGTA GATTGGGGTCAACTGGACTACTTAGTTGTAGACATGCCACCAGGAACTGGAGATGTGCAGTTATCAGTCTCACAGAATATTCCTATAACA GGTGCTGTGATTGTCTCCACGCCCCAGGACATCGCATTGATGGATGCACACAAGGGTGCTGAGATGTTTCGCAGAGTCCACGTGCCCGTC CTTGGCCTTGTCCAAAACATGAGTGTTTTCCAGTGTCCAAAATGTAAACACAAAACTCATATTTTTGGTGCTGATGGTGCAAGGAAACTA GCACAGACCCTTGGTCTTGAAGTTCTAGGAGACATTCCCTTACACCTTAATATAAGGGAAGCTTCAGATACAGGCCAGCCAATTGTGTTT TCACAGCCTGAAAGTGATGAGGCCAAAGCTTACTTGAGGATTGCTGTGGAAGTGGTAAGAAGATTGCCATCACCTTCAGAATGATTCCCC AAGTGTCCTGGAAATTTGCCTGGTACTGACATTAAGAGGACCTTTGGAAATCAGCAATGTGGTGATGGAACCTACAGAAATAATAGAAAT CATAACTGTTTTATTTCTAAGGAAAGAATGTCTTCATATTTGACTTGCTAAGCTAAGGTTCACAAAACTTTGATGTATCAATGTTAACTG CTATATTTAGGAATTTTTTGAAAGCTGGTGTGTACCACCTGCAAAGAACTGCATTTTATTTTATTGAATTACCCCTTTAGAAATCACGAG TTTATGATGTTACAAGTCCATTTTGGGAGAGAACTGTACACTTTTTGCAGGACCACAGAATTAGTAATTTAAATGATATACTAAATTTGT GTATGGGCATAAGTATTACGCCTTCCCACCAGGCAATTTGGACTGTCTTTGAATCCTGTCTTTGGTACTGTCTTGGACATGTTCTTAATA TGAACCTCTGCTTCTTCATCTGGATCACACTATACCCCAGACTTAATGAATTTCAGTCTCCAGGAGTGGAGCCTGAACATATGTATTTTT AGTAAGACCATGATGATGTTGATGATGATTCTGGTAATCATGGCAGTAAGAATAATAGCTAACATTTAACAAGTTAATTATAATTGTTCT TCCATTTGTGTGAGTGGGTACTATTATCTCCATTTTACAGATAAGTAATTTGAGATATAATTTGAAGGCACTCAACCTTGAGTGTCTTGC TGAGGGTTACTGTATCTAGCAGGTGATGGAGCTTGGATTTGAACTTGAGTAATTCGATATTAGATTCATCTTTTTGTACACCAATGTGCT TTTGTTAATTAAAAAAAGTCGGTGGTGGCTAGGCGTGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGTTGAGGTGGGTGGATCAT GAGGTCAGGAGTTCAAGACCAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCTGGGTGTGGTGGCATATG CCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCATTTCAACCCGGGAGGCTGAGGTTGCAGTGAGTGGAGATTGTACCACTG CACTCCAGCCTGGTCAATGGAGTGCGACTCCATCTCAAAAAAAAAAAAAAAAAAAAAAAAAGTCGGGGGAGATGCAATATTTAGCATTTC CTCAAACTTTTTTTGGCCATGAAATCCACCACCCCCCTCCTTTTTCAGAGCATTTCATGAAGTTCACATTTCAAATAATACATTTTGAAA AACATTTATCTTGTCTAATTGAAGCTCAAAGAGATAGAGTCAATGACTTTTCAAAGTCAGGTAGCAGATAGTTTTAAAGCTGCAAGTACT GATAAGTGTGAGCCATTAGTTAATTCGCATTTATAAAGAAGTGGTCTGTCACTTTTGGCAAATGTCTTGACATCTGTTGCTCTACAGTTG TCAACTAGAAAATTAGGCATAGAGTTTCACATTATTATAAGCATGTTTTCACACAAAAACATGTACATTGATGTTTATTGCAATTTTATG TGTAATAACCAAAAACAACCCAGATTTTCTTCATTGGGTAAATGATTAAACAAACCATAGTACATTCATACCGTGAGTGCTACTCAGCAA TAAAAAAGAACAAACTATGGGTACAGGCAGCAACTTATAATTCCAGAGAATTATGCTGAATGAAAAAGGCCAATTTAAAAAGGTTTTGTA CCAAAAGATTCCATTTATATAACGTTCTTGAAGTGACATAATTATAGAAATGGAGAACAGATTAGTGGTGGCTGTGTTAAGGAGGGGGTG AGGATGGGAGAGAATTGGGCGTGGCTGTGAGAAACATGAGGGATCCTTGTGATGATGGAAATGTTCTATATCACAGCTATCGATGTCAGT ATCCCAGTTGTGATATTGTGCTATAGTTTTGCAAGATGTTACCACTGGGGGAAATTGGGTGAAGGGCACATGGAATCTCTGTATTATTTC AACTGCATGTAAATCTACAATTATCTC >18359_18359_2_COL4A2-NUBPL_COL4A2_chr13_110960470_ENST00000360467_NUBPL_chr14_32068495_ENST00000536705_length(amino acids)=266AA_BP=42 MTGAQSGRTASMGRDQRAVAGPALRRWLLLGTVTVGFLAQSVLASKAIGLLDVDVYGPSVPKMMNLKGNPELSQSNLMRPLLNYGIACMS MGFLVEESEPVVWRGLMVMSAIEKLLRQVDWGQLDYLVVDMPPGTGDVQLSVSQNIPITGAVIVSTPQDIALMDAHKGAEMFRRVHVPVL GLVQNMSVFQCPKCKHKTHIFGADGARKLAQTLGLEVLGDIPLHLNIREASDTGQPIVFSQPESDEAKAYLRIAVEVVRRLPSPSE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for COL4A2-NUBPL |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for COL4A2-NUBPL |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for COL4A2-NUBPL |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | COL4A2 | C3280970 | PORENCEPHALY 2 | 4 | GENOMICS_ENGLAND;UNIPROT |
Hgene | COL4A2 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | COL4A2 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
Hgene | COL4A2 | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
Hgene | COL4A2 | C3281105 | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1 | GENOMICS_ENGLAND |
Hgene | COL4A2 | C4082173 | Porencephaly | 1 | CTD_human;GENOMICS_ENGLAND |
Tgene | C1838979 | MITOCHONDRIAL COMPLEX I DEFICIENCY | 4 | GENOMICS_ENGLAND;ORPHANET | |
Tgene | C0751651 | Mitochondrial Diseases | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C4748792 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 2 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0949855 | Electron Transport Chain Deficiencies, Mitochondrial | 1 | CTD_human | |
Tgene | C0949856 | Oxidative Phosphorylation Deficiencies | 1 | CTD_human | |
Tgene | C0949857 | Mitochondrial Respiratory Chain Deficiencies | 1 | CTD_human |